Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden Hospital.

[1]  K I Kaitin,et al.  Obstacles and Opportunities in New Drug Development , 2008, Clinical pharmacology and therapeutics.

[2]  D. Camidge,et al.  Dynamic and modern: bringing the ethics of phase I trials up to date. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  G. Pond,et al.  Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital , 2006, BMC Cancer.

[4]  Julian Downward,et al.  Cancer biology: Signatures guide drug choice , 2006, Nature.

[5]  P. Steeg.  Cancer biology: Emissaries set up new sites , 2005, Nature.

[6]  Seiichiro Yamamoto,et al.  Risks and benefits of phase 1 oncology trials, 1991 through 2002. , 2005, The New England journal of medicine.

[7]  C. Daugherty.  Ethical issues in phase I clinical trials. , 2004, Clinical advances in hematology & oncology : H&O.

[8]  J. Shaw,et al.  Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study , 2003, BMJ : British Medical Journal.

[9]  D. Gandara,et al.  Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C. Daugherty.  Ethical Issues in the Development of New Agents , 2004, Investigational New Drugs.